A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-06-29) →
What happened
OliX Pharmaceuticals disclosed a private placement (third-party allotment) to raise US$73.3M, about 4.0% of its market value.
For context, this raise equals about 4.0% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Private placement |
|---|---|
| Raise amount | US$73.3M |
| vs. market value | 4.0% |
| Filed | 2026-06-01, Material event report (rights offering) |
| Source | DART rcept 20260601002040 → open original filing |
Versions of this filing
- 2026-06-01Original (this page)
- 2026-06-29Amendment 1
Source: DART. Information only, not investment advice.